4//SEC Filing
COHEN MARC A 4
Accession 0001209191-21-025661
CIK 0001662579other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:30 PM ET
Size
7.2 KB
Accession
0001209191-21-025661
Insider Transaction Report
Form 4
COHEN MARC A
Director10% Owner
Transactions
- Award
Common Stock
2021-04-05$37.51/sh+553$20,743→ 6,119 total
Holdings
- 2,484,425(indirect: By Cobro Ventures Opportunity Fund, L.P.)
Common Stock
- 1,852,207(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.
- [F3]Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001132945
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 4:30 PM ET
- Size
- 7.2 KB